Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Transocean Ltd | Jeremy D. Thigpen | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,156,069 | 1,156,069 | - | - | Restricted Units | |
| Atlanticus Holdings Corp | David G. Hanna | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 1,000,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Atlanticus Holdings Corp | David G. Hanna | Director, Executive Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 10 Feb 2022 | 1,000,000 | 1,000,000 (6%) | 6% | 2.8 | 2,780,000 | Common Stock |
| PJT Partners Inc (Class A) | Paul J. Taubman | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,000,000 | 6,250,000 | - | - | LTIP Units of PJT Partners Holdings LP | |
| Porch Group Inc Ordinary | Matt Ehrlichman | Director, CEO, Chairman and Founder, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 883,740 | 883,740 | - | - | Performance-based Restricted Stock Units | |
| Lexicon Pharma Inc | Lonnel Coats | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 822,280 | 822,280 | - | - | Stock Option (Right to Buy) | |
| Estee Lauder (Class A) | Ronald S. Lauder | Director, Chairman, Clinique Labs, LLC, Ten Percent Owner | 10 Feb 2022 | 700,000 | 4,768,846 | - | - | Class B Common Stock | ||
| Estee Lauder (Class A) | Ronald S. Lauder | Director, Chairman, Clinique Labs, LLC, Ten Percent Owner | 10 Feb 2022 | 700,000 | 0 (0%) | 0% | 307.1 | 214,956,000 | Class A Common Stock | |
| Estee Lauder (Class A) | Ronald S. Lauder | Director, Chairman, Clinique Labs, LLC, Ten Percent Owner | 10 Feb 2022 | 700,000 | 700,000 (0%) | 0% | 0 | Class A Common Stock | ||
| Porch Group Inc Ordinary | Matt Ehrlichman | Director, CEO, Chairman and Founder, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 695,249 | 9,201,396 | - | 0 | Common Stock | |
| Atlanticus Holdings Corp | David G. Hanna | Director, Executive Chairman, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.95 per share. | 10 Feb 2022 | 473,136 | 526,864 (3%) | 2% | 69.9 | 33,095,863 | Common Stock |
| Brookdale Senior Living Inc | Lucinda M. Baier | Director, President and CEO | 10 Feb 2022 | 454,546 | 1,945,065 (1%) | 0% | 0 | Common Stock | ||
| Transocean Ltd | Keelan Adamson | Executive Vice President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 404,624 | 404,624 | - | - | Restricted Units | |
| Passage Bio Inc | Bruce Goldsmith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Transocean Ltd | Mark L. Mey | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 390,173 | 390,173 | - | - | Restricted Units | |
| Dynavax Tech Corp | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Jeffrey L. Wade | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 335,470 | 335,470 | - | - | Stock Option (Right to Buy) | |
| Vera Therapeutics Inc (Class A) | Patrick G. Enright | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 10 Feb 2022 | 333,333 | 3,429,927 | - | 15 | 4,999,995 | Class A Common Stock |
| Transocean Ltd | Brady Long | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 315,292 | 315,292 | - | - | Restricted Units | |
| Lexicon Pharma Inc | Lonnel Coats | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 274,090 | 274,090 | - | - | Restricted Stock Units | |
| Transocean Ltd | Jeremy D. Thigpen | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 270,706 | 1,598,285 (0%) | 0% | 0 | Registered Shares | |
| Lexicon Pharma Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 251,250 | 251,250 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Kenneth B. Kassler-Taub | SVP, Regulatory & QA | 10 Feb 2022 | 248,010 | 248,010 | - | - | Stock Option (Right to Buy) | ||
| Dow | James R. Fitterling | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 241,880 | 241,880 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Brian T. Crum | SVP, General Counsel & Secr. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 234,870 | 234,870 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Alan J. Main | EVP, Innov & Chem Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 230,990 | 230,990 | - | - | Stock Option (Right to Buy) | |
| Charles Schwab | Charles R. Schwab | Director, Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 220,064 | 75,277,907 (5%) | 0% | 0 | Common Stock | |
| Transocean Ltd | David A. Tonnel | SVP and Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 213,006 | 213,006 | - | - | Restricted Units | |
| Yum China Holdings Inc | Joey Wat | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 208,969 | 208,969 | - | - | Stock Appreciation Right | |
| Lexicon Pharma Inc | Kiernan A. Seth | VP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 206,670 | 206,670 | - | - | Stock Option (Right to Buy) | |
| AnaptysBio Inc | Hamza Suria | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| GoPro Inc (Class A) | Nicholas Woodman | Director, CEO, Chairman of the Board, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 200,000 | 200,000 (0%) | 0% | 0 | Class A Common Stock | |
| GoPro Inc (Class A) | Nicholas Woodman | Director, CEO, Chairman of the Board, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.96 per share. | 10 Feb 2022 | 200,000 | 0 (0%) | 0% | 9.0 | 1,791,380 | Class A Common Stock |
| GoPro Inc (Class A) | Nicholas Woodman | Director, CEO, Chairman of the Board, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 200,000 | 905,747 (0%) | 0% | 0 | Class A Common Stock | |
| Aethlon Medical Inc | Charles J. Fisher | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 192,600 | 192,600 | - | - | Employee Stock Option (Right to Buy) | |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & CHIEF SCIENCE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 191,708 | 192,708 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & CHIEF SCIENCE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 191,708 | 0 | - | - | Phantom Profit Units | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2022 | 184,939 | 448,704 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Feb 2022 | 184,939 | 448,704 | - | 0 | Common Stock | |
| Toast Inc (Class A) | Aman Narang | Director, COO & Co-President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.08 per share. | 10 Feb 2022 | 182,762 | 1,072,738 | - | 30.1 | 5,496,750 | Class A Common Stock |
| Lexicon Pharma Inc | Wendy E. McDermott | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 170,500 | 170,500 | - | - | Stock Option (Right to Buy) | |
| Passage Bio Inc | Alex Fotopoulos | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 163,900 | 163,900 | - | - | Stock Option (right to buy) | |
| Brookdale Senior Living Inc | Steven E. Swain | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 161,364 | 573,355 (0%) | 0% | 0 | Common Stock | |
| Passage Bio Inc | Simona King | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 159,000 | 159,000 | - | - | Stock Option (right to buy) | |
| Passage Bio Inc | Eliseo O. Salinas | Chief Res. & Develop Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 157,500 | 157,500 | - | - | Stock Option (right to buy) | |
| Immuneering Corp (Class A) | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 156,485 | 156,485 | - | - | Stock Option | |
| Dynavax Tech Corp | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Devon Energy | David A. Hager | Director, Executive Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.22 per share. | 10 Feb 2022 | 147,347 | 1,010,651 (0%) | 0% | 52.2 | 7,694,460 | Common Stock |
| Porch Group Inc Ordinary | Matt Ehrlichman | Director, CEO, Chairman and Founder, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 144,844 | 8,506,147 | - | 0 | Common Stock | |
| Calix Inc | John Matthew Collins | EVP, Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Collegium pharma Inc | Joseph Ciaffoni | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 125,000 | 388,904 (1%) | 0% | 0 | Common Stock | |
| Calix Inc | Shane Todd Marshall Eleniak | EVP, Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 123,479 | 23,000 | - | 0 | Common Stock | |
| Foghorn Therapeutics Inc | Adrian Gottschalk | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 123,479 | 448,704 | - | 0 | Common Stock | |
| Zevia PBC (Class A) | Padraic L. Spence | Director, Chair, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. | 10 Feb 2022 | 120,000 | 2,520,000 | - | 0.0 | 1,200 | Class A Common Stock |
| Zevia PBC (Class A) | Padraic L. Spence | Director, Chair, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 120,000 | 0 | - | - | Restricted Phantom Units | |
| Zentalis Pharma Inc | Anthony Y. Sun | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 118,319 | 118,319 | - | - | Stock Option (Right to Buy) | |
| Calix Inc | John Matthew Collins | EVP, Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 116,520 | 116,520 | - | - | Stock Option (right to buy) | |
| Calix Inc | Shane Todd Marshall Eleniak | EVP, Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 116,520 | 116,520 | - | - | Stock Option (right to buy) | |
| Lexicon Pharma Inc | Jeffrey L. Wade | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 111,820 | 111,820 | - | - | Restricted Stock Units | |
| Taylor Morrison Home Corp | Sheryl D. Palmer | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 111,562 | 111,562 | - | - | Employee Stock Option (Right to Buy) | |
| U.S. Bancorp | Andrew Cecere | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 109,412 | 962,335 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Citigroup | Paco Ybarra | CEO, Institutional Clients Grp | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 108,458 | 796,580 (0%) | 0% | 0 | Common Stock | |
| Varonis Systems Inc | Yakov Faitelson | Director, CEO, President, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 107,717 | 823,025 (2%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Transocean Ltd | Jeremy D. Thigpen | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 10 Feb 2022 | 107,061 | 1,491,224 (0%) | 0% | 3.6 | 386,490 | Registered Shares |
| Passage Bio Inc | Edgar B. Cale | GC and Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 106,000 | 106,000 | - | - | Stock Option (right to buy) | |
| Transocean Ltd | Mark L. Mey | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 104,415 | 685,439 (0%) | 0% | 0 | Registered Shares | |
| PMV Pharmaceuticals Inc | Winston Kung | COO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 104,400 | 104,400 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 104,400 | 104,400 | - | - | Employee Stock Option (right to buy) | |
| Passage Bio Inc | Monika Toernsen | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 101,000 | 101,000 | - | - | Stock Option (right to buy) | |
| Aethlon Medical Inc | James B. Frakes | CFO & Sr. VP ? Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 100,200 | 100,200 | - | - | Employee Stock Option (Right to Buy) | |
| Aethlon Medical Inc | Guy Cipriani | Director, Sr. V.P., Chief Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 100,200 | 100,200 | - | - | Employee Stock Option (Right to Buy) | |
| Aethlon Medical Inc | Steven P. Larosa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 100,200 | 100,200 | - | - | Employee Stock Option (Right to Buy) | |
| Calix Inc | Michael Weening | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 97,100 | 97,100 | - | - | Stock Option (right to buy) | |
| First Horizon Corp | Daryl G. Byrd | Director, Executive Chairman of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 93,833 | 1,732,685 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corp | D. Bryan Jordan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 93,833 | 1,265,364 (0%) | 0% | 0 | Common Stock | |
| Marcus & Millichap Inc | Hessam Nadji | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 92,000 | 92,000 | - | - | Restricted Stock Units | |
| Archer-Daniels-Midland | Juan R. Luciano | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 91,756 | 848,621 (0%) | 0% | 0 | Common Stock | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 91,047 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc (Class A) | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 91,047 | 91,047 | - | - | Employee Stock Option (Right to Buy) | |
| Dynavax Tech Corp | Kelly MacDonald | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 90,500 | 90,500 | - | - | Stock Option (Right to Buy) | |
| Zevia PBC (Class A) | Harry Margolis | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 90,000 | 0 | - | - | Restricted Phantom Units | |
| Zevia PBC (Class A) | Harry Margolis | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. | 10 Feb 2022 | 90,000 | 810,000 | - | 0.0 | 900 | Class A Common Stock |
| Zevia PBC (Class A) | Robert Gay | Chief Strategy Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 90,000 | 0 | - | - | Restricted Phantom Units | |
| Zevia PBC (Class A) | Robert Gay | Chief Strategy Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. | 10 Feb 2022 | 90,000 | 940,000 | - | 0.0 | 900 | Class A Common Stock |
| Varonis Systems Inc | David Bass | EVP Engineering & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 89,652 | 241,487 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Dynavax Tech Corp | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 89,250 | 160,839 (0%) | 0% | 0 | Common Stock | |
| Dynavax Tech Corp | Ryan Spencer | Director, CEO and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 89,250 | 0 | - | - | Restricted Stock Unit | |
| Dow | Howard I. Ungerleider | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 84,120 | 84,120 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 83,750 | 83,750 | - | - | Restricted Stock Units | |
| Immuneering Corp (Class A) | Brett Hall | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 83,100 | 83,100 | - | - | Stock Option | |
| Lexicon Pharma Inc | Kenneth B. Kassler-Taub | SVP, Regulatory & QA | 10 Feb 2022 | 82,670 | 82,670 | - | - | Restricted Stock Units | ||
| PotlatchDeltic Corp | Michael J. Covey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 80,816 | 228,575 (0%) | 0% | 0 | Common Stock | |
| Pluri Inc | Zami Aberman | Director | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 10 Feb 2022 | 80,616 | 91,756 (0%) | 0% | 1.8 | 145,109 | Common Stock |
| Lexicon Pharma Inc | Brian T. Crum | SVP, General Counsel & Secr. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 78,290 | 78,290 | - | - | Restricted Stock Units | |
| Calix Inc | Cory J. Sindelar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 77,680 | 77,680 | - | - | Stock Option (right to buy) | |
| Transocean Ltd | Brady Long | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 77,345 | 408,555 (0%) | 0% | 0 | Registered Shares | |
| Brookdale Senior Living Inc | Kevin W. Bowman | EVP-Community Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 77,273 | 139,995 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharma Inc | Alan J. Main | EVP, Innov & Chem Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 77,000 | 77,000 | - | - | Restricted Stock Units | |
| IQVIA | Ari Bousbib | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 76,472 | 76,472 | - | - | Stock Appreciation Right | |
| Ameren | Warner L. Baxter | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 75,962 | 409,740 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Taylor Morrison Home Corp | Sheryl D. Palmer | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 75,653 | 75,653 | - | - | Restricted Stock Units | |
| Brookdale Senior Living Inc | Lucinda M. Baier | Director, President and CEO | 10 Feb 2022 | 75,541 | 1,490,519 (0%) | 0% | 0 | Common Stock | ||
| Dynavax Tech Corp | Robert Janssen | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc (Class A) | Alessandra Pavesio | SVP & CHIEF SCIENCE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.88 per share. | 10 Feb 2022 | 73,915 | 118,793 (0%) | 0% | 12.9 | 952,025 | Class A Common Stock |
| Telephone And Data Systems Inc | Leroy T. Carlson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 72,850 | 125,022 (0%) | 0% | 0 | Common Shares | |
| Capri Holdings Ltd | John D. Idol | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.10 per share. | 10 Feb 2022 | 72,397 | 1,005,665 (0%) | 0% | 47.1 | 3,409,899 | Ordinary shares, no par value |
| Capri Holdings Ltd | John D. Idol | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 72,397 | 35,207 | - | - | Employee share option (right to buy) | |
| Leidos | Roger A. Krone | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 71,921 | 226,497 (0%) | 0% | 0 | Common Stock | |
| Immuneering Corp (Class A) | Scott Barrett | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 71,850 | 71,850 | - | - | Stock Option | |
| Universal Electronics Inc | Paul D. Arling | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 70,610 | 457,815 | - | - | Emp Stock Option (Rt. to Buy) | |
| Immuneering Corp (Class A) | Biren Amin | CFO, TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 70,050 | 70,050 | - | - | Stock Option | |
| AnaptysBio Inc | Eric J. Loumeau | COO, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Dennis M. Mulroy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Paul F. Lizzul | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Transocean Ltd | Keelan Adamson | Executive Vice President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 69,610 | 355,981 (0%) | 0% | 0 | Registered Shares | |
| Lexicon Pharma Inc | Kiernan A. Seth | VP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 68,890 | 68,890 | - | - | Restricted Stock Units | |
| PMV Pharmaceuticals Inc | Deepika Jalota | SVP, Regulatory Affairs and QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 68,100 | 68,100 | - | - | Employee Stock Option (right to buy) | |
| Devon Energy | Richard E. Muncrief | Director, President and CEO | 10 Feb 2022 | 67,025 | 2,200,381 (0%) | 0% | 0 | Common Stock | ||
| Cheesecake Factory Inc | David Overton | Director, CHAIRMAN AND C.E.O. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 66,700 | 139,700 (0%) | 0% | 0 | Common Stock | |
| Bioventus Inc (Class A) | John E. Nosenzo | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 66,139 | 66,639 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc (Class A) | John E. Nosenzo | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 66,139 | 0 | - | - | Phantom Profit Units | |
| Bioventus Inc (Class A) | Gregory O. Anglum | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 65,581 | 71,581 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc (Class A) | Gregory O. Anglum | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 65,581 | 0 | - | - | Phantom Profit Units | |
| Capri Holdings Ltd | John D. Idol | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 70.29 per share. | 10 Feb 2022 | 65,121 | 940,544 (0%) | 0% | 70.3 | 4,577,355 | Ordinary shares, no par value |
| Collegium pharma Inc | Joseph Ciaffoni | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 65,034 | 453,938 (1%) | 0% | - | Common Stock | |
| TMC the metals Co Inc | Kathleen S. McAllister | Director | 10 Feb 2022 | 64,516 | 64,516 | - | 0 | Common Shares | ||
| Barnes Grp Inc | Patrick J. Dempsey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 64,500 | 64,500 | - | - | Employee Stock Option-Right to Buy | |
| Citigroup | Jane Nind Fraser | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 63,628 | 322,499 (0%) | 0% | 0 | Common Stock | |
| Churchill Downs Inc | William C. Carstanjen | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 63,219 | 641,232 (1%) | 0% | 0 | Common Stock | |
| Dynavax Tech Corp | Ryan Spencer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 62,500 | 62,500 | - | - | Restricted Stock Unit | |
| Piedmont Office Realty Trust Inc (Class A) | Christopher Brent Smith | Director, President & Chief Exec. Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 62,315 | 112,150 | - | - | Restricted Stock Units | |
| Brookdale Senior Living Inc | Chad C. White | EVP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 59,091 | 263,911 (0%) | 0% | 0 | Common Stock | |
| Marcus & Millichap Inc | John David Parker | EVP & COO - Eastern Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 58,788 | 58,788 | - | - | Restricted Stock Units | |
| Marcus & Millichap Inc | Richard D. Matricaria | EVP & COO - Western Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 58,788 | 58,788 | - | - | Restricted Stock Units | |
| Varonis Systems Inc | Guy Melamed | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 57,352 | 480,235 (1%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Lexicon Pharma Inc | Wendy E. McDermott | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 56,830 | 56,830 | - | - | Restricted Stock Units | |
| Collegium pharma Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2022 | 56,700 | 145,956 (0%) | 0% | 0 | Common Stock | ||
| Citigroup | David Livingstone | CEO, Europe,Middle East&Africa | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 54,597 | 177,695 (0%) | 0% | 0 | Common Stock | |
| Zentalis Pharma Inc | Kevin D. Bunker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 52,745 | 52,745 | - | - | Stock Option (Right to Buy) | |
| Collegium pharma Inc | Scott Dreyer | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 52,500 | 128,769 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | Colleen Tupper | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 52,500 | 94,500 (0%) | 0% | 0 | Common Stock | |
| Dynavax Tech Corp | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 52,500 | 96,566 (0%) | 0% | - | Common Stock | |
| Dynavax Tech Corp | David Novack | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 52,500 | 0 | - | - | Restricted Stock Unit | |
| Transocean Ltd | David A. Tonnel | SVP and Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 51,821 | 270,978 (0%) | 0% | 0 | Registered Shares | |
| Dow | Attiganal N. Sreeram | Senior Vice President / CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 51,270 | 51,270 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Dow | Amy E. Wilson | General Counsel / Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 51,270 | 51,270 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Yum China Holdings Inc | Andy Yeung | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 50,796 | 50,796 | - | - | Stock Appreciation Right | |
| Zentalis Pharma Inc | Anthony Y. Sun | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 50,431 | 1,222,206 | - | 0 | Common Stock | |
| PJT Partners Inc (Class A) | Ji-Yeun Lee | Managing Partner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 50,410 | 755,410 | - | - | LTIP Units of PJT Partners Holdings LP | |
| PNC Financial | William S. Demchak | President/CEO | Grant, award, or other acquisition of securities at price $ 210.63 per share. | 10 Feb 2022 | 48,468 | 482,411 (0%) | 0% | 210.6 | 10,208,815 | $5 Par Common Stock |
| Lexicon Pharma Inc | Kristen L. Alexander | VP, Finance and Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 47,780 | 47,780 | - | - | Stock Option (Right to Buy) | |
| Cheesecake Factory Inc | David Overton | Director, CHAIRMAN AND C.E.O. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 47,400 | 47,400 | - | - | Restricted Stock | |
| Immuneering Corp (Class A) | Michael D. Bookman | GENERAL COUNSEL AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 47,300 | 47,300 | - | - | Stock Option | |
| U.S. Bancorp | Terrance R. Dolan | Vice Chair & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 47,276 | 166,501 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Citigroup | Ernesto Torres Cantu | CEO, Latin America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 46,669 | 96,317 (0%) | 0% | 0 | Common Stock | |
| NexPoint Diversified Real Estate Trust | James D. Dondero | See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.04 per share. | 10 Feb 2022 | 46,190 | 2,976,031 (6%) | 0% | 15.0 | 694,698 | Common Stock |
| Citigroup | Michael Whitaker | Head of Enterprise O&T | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 45,687 | 159,922 (0%) | 0% | 0 | Common Stock | |
| Immuneering Corp (Class A) | Benjamin J. Zeskind | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 45,615 | 202,100 | - | - | Stock Option | |
| Varonis Systems Inc | James O’Boyle | SVP of Worldwide Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 45,416 | 375,423 (1%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Louisiana-Pacific Corp | William Bradley Southern | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.89 per share. | 10 Feb 2022 | 44,538 | 473,554 (0%) | 0% | 67.9 | 3,023,685 | Common Stock |
| Louisiana-Pacific Corp | William Bradley Southern | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 44,538 | 0 | - | - | Performance Stock Units | |
| Zevia PBC (Class A) | Padraic L. Spence | Director, Chair, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.38 per share. | 10 Feb 2022 | 44,378 | 2,475,464 | - | 9.4 | 416,266 | Class A Common Stock |
| Marcus & Millichap Inc | Steven F. DeGennaro | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 44,272 | 44,272 | - | - | Restricted Stock Units | |
| Clear Channel Outdoor Holdings Inc | Andrew W. Hobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 44,247 | 435,758 (0%) | 0% | 0 | Common Stock | |
| Clear Channel Outdoor Holdings Inc | W. Benjamin Moreland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 44,247 | 1,180,095 (2%) | 0% | 0 | Common Stock | |
| Clear Channel Outdoor Holdings Inc | Mary Teresa Rainey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 44,247 | 235,758 (0%) | 0% | 0 | Common Stock | |
| Clear Channel Outdoor Holdings Inc | John Dionne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 44,247 | 283,552 (0%) | 0% | 0 | Common Stock | |
| Citigroup | Anand Selvakesari | CEO, Personal Bkg & Wealth Mgt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 43,981 | 151,722 (0%) | 0% | 0 | Common Stock | |
| Citigroup | Peter Babej | CEO, Asia Pacific | 10 Feb 2022 | 43,963 | 130,403 (0%) | 0% | 0 | Common Stock | ||
| Timken Co. | Richard Kyle | Director, President and CEO | 10 Feb 2022 | 43,575 | 43,575 | - | - | Restricted Share Unit | ||
| Devon Energy | Jeffrey L. Ritenour | EVP & CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.22 per share. | 10 Feb 2022 | 43,338 | 337,016 (0%) | 0% | 52.2 | 2,263,110 | Common Stock |
| Yum China Holdings Inc | Johnson Huang | General Manager, KFC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 42,759 | 42,759 | - | - | Stock Appreciation Right | |
| EQT | Toby Z. Rice | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.67 per share. | 10 Feb 2022 | 41,389 | 833,951 (0%) | 0% | 21.7 | 896,900 | Common Stock |
| Transocean Ltd | Mark L. Mey | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 10 Feb 2022 | 41,297 | 644,142 (0%) | 0% | 3.6 | 149,082 | Registered Shares |
| PJT Partners Inc (Class A) | Helen T. Meates | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 41,146 | 181,146 | - | - | LTIP Units of PJT Partners Holdings LP | |
| Brookdale Senior Living Inc | H. Todd Kaestner | EVP-Corp Dev & Pres-CCRCs | 10 Feb 2022 | 40,910 | 247,199 (0%) | 0% | 0 | Common Stock | ||
| Arista Networks | Kenneth Duda | CTO and SVP Software Eng. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.94 per share. | 10 Feb 2022 | 40,000 | 60,117 (0%) | 0% | 1.9 | 77,600 | Common Stock |
| Arista Networks | Kenneth Duda | CTO and SVP Software Eng. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 40,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Dow | John Maurice Sampson | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 39,540 | 39,540 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Loews | Kenneth I. Siegel | Senior Vice President | Sale or transfer of securities back to the company at price $ 61.82 per share. | 10 Feb 2022 | 39,362 | 26,871 (0%) | 0% | 61.8 | 2,433,359 | Common Stock |
| Louisiana-Pacific Corp | William Bradley Southern | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 39,353 | 39,353 | - | - | Performance Stock Unit | |
| Yum China Holdings Inc | Joseph Chan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 38,579 | 38,579 | - | - | Stock Appreciation Right | |
| First Fin Bancorp | Claude E. Davis | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 25.56 per share. | 10 Feb 2022 | 38,538 | 137,819 (0%) | 0% | 25.6 | 985,031 | Common Stock |
| Zentalis Pharma Inc | Melissa B. Epperly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 38,489 | 38,489 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharma Inc | Alexis Pinto | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 38,489 | 38,489 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc (Class A) | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 38,288 | 38,288 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc (Class A) | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 38,288 | 0 | - | - | Phantom Profit Units | |
| NexPoint Diversified Real Estate Trust | James D. Dondero | See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.06 per share. | 10 Feb 2022 | 37,635 | 2,918,283 (6%) | 0% | 15.1 | 566,783 | Common Stock |
| Clear Channel Outdoor Holdings Inc | W. Benjamin Moreland | Director | Grant, award, or other acquisition of securities at price $ 3.39 per share. | 10 Feb 2022 | 36,873 | 1,216,968 (2%) | 0% | 3.4 | 124,999 | Common Stock |
| ASGN Inc | Randolph C. Blazer | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 36,825 | 120,269 (0%) | 0% | 0 | Common Stock | |
| Collegium pharma Inc | Richard Malamut | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 36,750 | 130,308 (0%) | 0% | 0 | Common Stock | |
| Dow | Karen S. Carter | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 36,470 | 36,470 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Datadog Inc (Class A) | Dev C. Ittycheria | Director | Sale of securities on an exchange or to another person at price $ 170.14 per share. | 10 Feb 2022 | 35,370 | 203,029 (0%) | 0% | 170.1 | 6,017,781 | Class A Common Stock |
| Datadog Inc (Class A) | Dev C. Ittycheria | Director | Sale of securities on an exchange or to another person at price $ 170.14 per share. | 10 Feb 2022 | 35,370 | 242,578 (0%) | 0% | 170.1 | 6,017,781 | Class A Common Stock |
| Cisco | R. Scott Herren | EVP and CFO | 10 Feb 2022 | 34,351 | 236,097 (0%) | 0% | 56.3 | 1,933,618 | Common Stock | |
| Philip Morris | Jacek Olczak | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 102.69 per share. | 10 Feb 2022 | 34,100 | 333,110 (0%) | 0% | 102.7 | 3,501,865 | Common Stock |
| U.S. Bancorp | Jeffry H. von Gillern | Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 33,769 | 127,077 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| eXp World Holdings Inc | Jason Gesing | Director, CEO of eXp Realty, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 29.61 per share. | 10 Feb 2022 | 33,761 | 2,127,312 (3%) | 0% | 29.6 | 999,825 | Common Stock |
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 33,692 | 14,181 | - | - | Employee Stock Option (Right to Buy) | |
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 449.01 per share. | 10 Feb 2022 | 33,692 | 196,390 (0%) | 0% | 449.0 | 15,128,045 | Class A Common Stock |
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. | 10 Feb 2022 | 33,692 | 230,082 (0%) | 0% | 6.5 | 218,998 | Class A Common Stock |
| Dow | Jane Palmieri | President, Ind Interm & Infras | 10 Feb 2022 | 33,580 | 33,580 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Citigroup | Karen B. Peetz | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 33,412 | 45,943 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | William E. Waltz | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 118.33 per share. | 10 Feb 2022 | 33,000 | 59,017 (0%) | 0% | 118.3 | 3,904,920 | Common Stock |
| Dow | James R. Fitterling | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 32,980 | 129,046 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 32,795 | 32,794 | - | - | Restricted Stock Units | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 32,795 | 584,639 (0%) | 0% | 0 | Common Stock | |
| Piedmont Office Realty Trust Inc (Class A) | Robert E. Bowers | EVP-CFO&Admin Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 32,641 | 63,827 | - | - | Restricted Stock Units | |
| Snap-on | Nicholas T. Pinchuk | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 32,286 | 32,286 | - | - | Stock Option (Right to Buy) | |
| Zevia PBC (Class A) | Harry Margolis | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.38 per share. | 10 Feb 2022 | 31,863 | 778,019 | - | 9.4 | 298,875 | Class A Common Stock |
| Lexicon Pharma Inc | Kristen L. Alexander | VP, Finance and Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 31,850 | 31,850 | - | - | Restricted Stock Units | |
| Dow | Mauro Gregorio | President, Perf Mat & Coatings | 10 Feb 2022 | 31,590 | 31,590 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Capri Holdings Ltd | John D. Idol | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 31,404 | 3,803 | - | - | Employee share option (right to buy) | |
| Capri Holdings Ltd | John D. Idol | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 69.25 per share. | 10 Feb 2022 | 31,404 | 933,268 (0%) | 0% | 69.3 | 2,174,727 | Ordinary shares, no par value |
| Capri Holdings Ltd | John D. Idol | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.10 per share. | 10 Feb 2022 | 31,404 | 964,672 (0%) | 0% | 47.1 | 1,479,128 | Ordinary shares, no par value |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 31,282 | 568,442 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 31,282 | 62,562 | - | - | Restricted Stock Units | |
| First Horizon Corp | Anthony J. Restel | President-Regional Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 30,956 | 459,925 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corp | David T. Popwell | President-Specialty Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 30,956 | 485,037 (0%) | 0% | 0 | Common Stock | |
| Charles Schwab | Charles R. Schwab | Director, Chairman | Sale of securities on an exchange or to another person at price $ 95.50 per share. | 10 Feb 2022 | 30,873 | 75,497,971 (5%) | 0% | 95.5 | 2,948,430 | Common Stock |
| PNC Financial | E. William Parsley | Executive Vice President | Grant, award, or other acquisition of securities at price $ 210.63 per share. | 10 Feb 2022 | 30,843 | 156,293 (0%) | 0% | 210.6 | 6,496,461 | $5 Par Common Stock |
| PNC Financial | Michael P. Lyons | Executive Vice President | Grant, award, or other acquisition of securities at price $ 210.63 per share. | 10 Feb 2022 | 30,843 | 188,792 (0%) | 0% | 210.6 | 6,496,461 | $5 Par Common Stock |
| Transocean Ltd | Brady Long | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 10 Feb 2022 | 30,591 | 377,964 (0%) | 0% | 3.6 | 110,434 | Registered Shares |
| Citigroup | Johnbull Okpara | Controller&Chief Acct. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 30,530 | 48,004 (0%) | 0% | 0 | Common Stock | |
| Universal Electronics Inc | Paul D. Arling | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 30,385 | 60,548 | - | - | Restricted Stock Units | |
| Dynavax Tech Corp | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 30,000 | 0 | - | - | Restricted Stock Unit | |
| Dynavax Tech Corp | Robert Janssen | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 30,000 | 38,276 (0%) | 0% | - | Common Stock | |
| Sabre Corp | Sean E. Menke | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 10 Feb 2022 | 30,000 | 929,909 (0%) | 0% | 10.0 | 300,273 | Common Stock |
| Surgery Partners Inc | J. Eric Evans | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 42.04 per share. | 10 Feb 2022 | 29,732 | 391,449 (0%) | 0% | 42.0 | 1,249,933 | Common Stock |
| Dow | Diego Donoso | President, Pkg & Spec Plastics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 29,610 | 29,610 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| PotlatchDeltic Corp | Eric J. Cremers | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 29,397 | 178,199 (0%) | 0% | 0 | Common Stock | |
| Devon Energy | Clay M. Gaspar | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 29,108 | 881,961 (0%) | 0% | 0 | Common Stock | |
| Timken Co. | Richard Kyle | Director, President and CEO | 10 Feb 2022 | 29,050 | 29,050 | - | - | Restricted Share Unit | ||
| Baxter International | Jose E. Almeida | Chairman, CEO and President | 10 Feb 2022 | 28,978 | 308,966 (0%) | 0% | 0 | Common Stock, $1 par value | ||
| Collegium pharma Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.63 per share. | 10 Feb 2022 | 28,843 | 400,941 (1%) | 0% | 17.6 | 508,502 | Common Stock |
| First Horizon Corp | Tammy LoCascio | SEVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 28,745 | 156,270 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 28,729 | 596,102 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 28,729 | 0 | - | - | Restricted Stock Units | |
| Biogen | Michel Vounatsos | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 28,405 | 28,405 | - | - | Restricted Stock Unit | |
| Churchill Downs Inc | William C. Carstanjen | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.45 per share. | 10 Feb 2022 | 28,403 | 612,829 (1%) | 0% | 224.4 | 6,375,053 | Common Stock |
| U.S. Bancorp | Shailesh M. Kotwal | Vice Chair | 10 Feb 2022 | 28,365 | 79,628 (0%) | 0% | 0 | Common Stock, $0.01 par value | ||
| U.S. Bancorp | Gunjan Kedia | Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 28,365 | 112,891 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| U.S. Bancorp | Timothy A Welsh | Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 28,365 | 107,337 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Sunstone Hotel Investors Inc | Bryan A. Giglia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 28,048 | 542,595 (0%) | 0% | - | Common Stock | |
| Sunstone Hotel Investors Inc | Bryan A. Giglia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 28,048 | 570,643 (0%) | 0% | - | Common Stock | |
| Masco | Donald R. Parfet | Director | 10 Feb 2022 | 27,924 | 6,150 (0%) | 0% | 0 | Common Stock | ||
| Transocean Ltd | Keelan Adamson | Executive Vice President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 10 Feb 2022 | 27,532 | 328,499 (0%) | 0% | 3.6 | 99,391 | Registered Shares |
| Brookdale Senior Living Inc | George T. Hicks | EVP & Treasurer | 10 Feb 2022 | 27,273 | 271,081 (0%) | 0% | 0 | Common Stock | ||
| Amazon | Jeffrey P. Bezos | Director, Executive Chair, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 27,086 | 49,936,961 (10%) | 0% | 0 | Common Stock, par value $.01 per share | |
| ON Semiconductor | Thad Trent | Exec VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 26,806 | 104,767 (0%) | 0% | 0 | Common | |
| Churchill Downs Inc | William E. Mudd | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 26,788 | 297,486 (0%) | 0% | 0 | Common Stock | |
| Marcus & Millichap Inc | Gregory A. LaBerge | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 26,766 | 26,766 | - | - | Restricted Stock Units | |
| Zevia PBC (Class A) | Robert Gay | Chief Strategy Officer & EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.38 per share. | 10 Feb 2022 | 26,616 | 913,266 | - | 9.4 | 249,658 | Class A Common Stock |
| Dynavax Tech Corp | David Novack | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 26,500 | 26,500 | - | - | Restricted Stock Unit | |
| Telephone And Data Systems Inc | Leroy T. Carlson | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.32 per share. | 10 Feb 2022 | 26,360 | 98,662 (0%) | 0% | 20.3 | 535,635 | Common Shares |
| Citigroup | Edward Skyler | Head of Global Public Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 26,324 | 173,520 (0%) | 0% | 0 | Common Stock | |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 26,242 | 26,242 | - | - | Employee Stock Option (Right to Buy) | |
| Louisiana-Pacific Corp | William Bradley Southern | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 68.61 per share. | 10 Feb 2022 | 26,235 | 482,263 (0%) | 0% | 68.6 | 1,799,983 | Common Stock |
| Citigroup | Sunil Garg | CEO, Citibank, N.A. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 26,047 | 55,210 (0%) | 0% | 0 | Common Stock | |
| Omnicell Inc | Vance B. Moore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 25,951 | 25,951 | - | - | Stock Option NQ (Right to Buy) | |
| Omnicell Inc | Vance B. Moore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 25,951 | 67,218 (0%) | 0% | 0 | Common Stock | |
| Yum China Holdings Inc | Joey Wat | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 25,918 | 25,918 | - | - | Restricted Stock Unit | |
| Citigroup | Mary McNiff | Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 25,296 | 70,828 (0%) | 0% | 0 | Common Stock | |
| Philip Morris | Andre Calantzopoulos | Director, Exec. Chairman of the Board | Grant, award, or other acquisition of securities at price $ 102.69 per share. | 10 Feb 2022 | 25,220 | 905,964 (0%) | 0% | 102.7 | 2,589,943 | Common Stock |
| Archer-Daniels-Midland | Ray G. Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 25,025 | 594,236 (0%) | 0% | 0 | Common Stock | |
| Brixmor Property Grp Inc | James M. Taylor | President and CEO | 10 Feb 2022 | 25,000 | 526,661 (0%) | 0% | 25.5 | 636,750 | Common Stock | |
| Citigroup | Sara Wechter | Head of Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,863 | 71,843 (0%) | 0% | 0 | Common Stock | |
| Brookdale Senior Living Inc | Frank M. Bumstead | Director | 10 Feb 2022 | 24,545 | 351,291 (0%) | 0% | 0 | Common Stock | ||
| Brookdale Senior Living Inc | Guy P. Sansone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,545 | 68,285 (0%) | 0% | 0 | Common Stock | |
| Brookdale Senior Living Inc | Lee S. Wielansky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,545 | 152,405 (0%) | 0% | 0 | Common Stock | |
| Brookdale Senior Living Inc | Victoria L. Freed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,545 | 68,285 (0%) | 0% | 0 | Common Stock | |
| Brookdale Senior Living Inc | Marcus E. Bromley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,545 | 126,238 (0%) | 0% | 0 | Common Stock | |
| Brookdale Senior Living Inc | Denise W. Warren | Director | 10 Feb 2022 | 24,545 | 99,673 (0%) | 0% | 0 | Common Stock | ||
| Brookdale Senior Living Inc | Rita Johnson-Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,545 | 99,136 (0%) | 0% | 0 | Common Stock | |
| Brookdale Senior Living Inc | Jordan R. Asher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,545 | 74,402 (0%) | 0% | 0 | Common Stock | |
| CTS Corp | Kieran O'Sullivan | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,528 | 500,566 (1%) | 0% | 0 | Common Stock | |
| Devon Energy | Jeffrey L. Ritenour | EVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,512 | 341,017 (0%) | 0% | 0 | Common Stock | |
| Devon Energy | David G. Harris | EVP Chief Corp Develop Officer | 10 Feb 2022 | 24,512 | 189,029 (0%) | 0% | 0 | Common Stock | ||
| Dow | Attiganal N. Sreeram | Senior Vice President / CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,325 | 116,503 (0%) | 0% | 0 | Common Stock | |
| U.S. Bancorp | Kate Quinn | Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,313 | 108,714 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Zentalis Pharma Inc | Dimitris Voliotis | SVP, Clinical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,234 | 24,234 | - | - | Stock Option (Right to Buy) | |
| Bioventus Inc (Class A) | John E. Nosenzo | CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.88 per share. | 10 Feb 2022 | 24,205 | 42,434 (0%) | 0% | 12.9 | 311,760 | Class A Common Stock |
| Collegium pharma Inc | Joseph Ciaffoni | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.63 per share. | 10 Feb 2022 | 24,154 | 429,784 (1%) | 0% | 17.6 | 425,835 | Common Stock |
| Yum China Holdings Inc | Jeff Kuai | General Manager, Pizza Hut | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,112 | 24,112 | - | - | Stock Appreciation Right | |
| Yum China Holdings Inc | Aiken Yuen | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 24,112 | 24,112 | - | - | Stock Appreciation Right | |
| Sunstone Hotel Investors Inc | Robert C. Springer | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 23,741 | 507,390 (0%) | 0% | - | Common Stock | |
| Sunstone Hotel Investors Inc | Robert C. Springer | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 23,741 | 483,649 (0%) | 0% | - | Common Stock | |
| Polaris Inc | Lucy Clark Dougherty | SVP-Gen Counsel & Secretary | 10 Feb 2022 | 23,734 | 27,063 (0%) | 0% | 120 | 2,848,080 | Common Stock | |
| U.S. Bancorp | Jodi L. Richard | Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 23,639 | 81,614 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Brookdale Senior Living Inc | Dawn L. Kussow | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 23,303 | 106,010 (0%) | 0% | 0 | Common Stock | |
| Baxter International | Jose E. Almeida | Chairman, CEO and President | 10 Feb 2022 | 23,230 | 285,736 (0%) | 0% | 87.8 | 2,038,433 | Common Stock, $1 par value | |
| First Horizon Corp | Susan L. Springfield | Sr EVP & Chief Credit Officer | 10 Feb 2022 | 23,217 | 247,412 (0%) | 0% | 0 | Common Stock | ||
| CTS Corp | Kieran O'Sullivan | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 22,982 | 519,301 (1%) | 0% | 0 | Common Stock | |
| Zentalis Pharma Inc | Kevin D. Bunker | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 22,481 | 768,798 | - | 0 | Common Stock | |
| MGP Ingredients Inc | David J. Colo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 22,020 | 64,160 (0%) | 0% | 0 | Common Stock | |
| Ameren | Martin J. Lyons | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 21,756 | 214,690 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Dow | Ronald C. Edmonds | Controller and Vice President | 10 Feb 2022 | 21,670 | 21,670 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| U.S. Bancorp | James L. Chosy | Senior EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 21,612 | 135,881 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| U.S. Bancorp | James B. Kelligrew | Vice Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 21,612 | 89,509 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Voya Fin Inc | Nancy Ferrara | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.60 per share. | 10 Feb 2022 | 21,480 | 35,296 (0%) | 0% | 37.6 | 807,648 | Common Stock |
| Voya Fin Inc | Nancy Ferrara | See Remarks | Sale of securities on an exchange or to another person at price $ 72.74 per share. | 10 Feb 2022 | 21,480 | 13,816 (0%) | 0% | 72.7 | 1,562,417 | Common Stock |
| Voya Fin Inc | Nancy Ferrara | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 21,480 | 71,174 | - | - | Performance-Based Stock Options | |
| Leidos | Roger A. Krone | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 21,440 | 225,600 (0%) | 0% | 0 | Common Stock | |
| PNC Financial | William S. Demchak | President/CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.63 per share. | 10 Feb 2022 | 21,332 | 461,079 (0%) | 0% | 210.6 | 4,493,159 | $5 Par Common Stock |
| Barnes Grp Inc | Patrick J. Dempsey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 21,200 | 430,058 (0%) | 0% | 0 | Common Stock | |
| Bioventus Inc (Class A) | Anthony D’Adamio | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 21,165 | 0 | - | - | Phantom Profit Units | |
| Bioventus Inc (Class A) | Anthony D’Adamio | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 21,165 | 22,165 (0%) | 0% | - | Class A Common Stock | |
| Dow | Amy E. Wilson | General Counsel / Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 21,054 | 59,533 (0%) | 0% | 0 | Common Stock | |
| Yum China Holdings Inc | Leila Zhang | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 20,897 | 20,897 | - | - | Stock Appreciation Right | |
| Devon Energy | David G. Harris | EVP Chief Corp Develop Officer | 10 Feb 2022 | 20,802 | 180,671 (0%) | 0% | 52.2 | 1,086,280 | Common Stock | |
| Devon Energy | David A. Hager | Director, Executive Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.22 per share. | 10 Feb 2022 | 20,789 | 958,347 (0%) | 0% | 52.2 | 1,085,602 | Common Stock |
| Brookdale Senior Living Inc | Steven E. Swain | EVP & Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Feb 2022 | 20,674 | 411,991 (0%) | 0% | 0 | Common Stock | |
| IQVIA | Ari Bousbib | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 20,542 | 713,740 (0%) | 0% | 0 | Common Stock | |
| Balchem Corp | Theodore L. Harris | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 20,500 | 174,280 | - | - | Stock Option | |
| Transocean Ltd | David A. Tonnel | SVP and Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.61 per share. | 10 Feb 2022 | 20,497 | 250,481 (0%) | 0% | 3.6 | 73,994 | Registered Shares |
| Taylor Morrison Home Corp | Sheryl D. Palmer | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 20,294 | 20,295 | - | - | Restricted Stock Units | |
| Taylor Morrison Home Corp | Sheryl D. Palmer | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 20,294 | 232,116 (0%) | 0% | - | Common Stock | |
| AMD | Mark D. Papermaster | Chief Technology Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.98 per share. | 10 Feb 2022 | 20,180 | 1,314,812 (0%) | 0% | 7.0 | 140,856 | Common Stock |
| AMD | Mark D. Papermaster | Chief Technology Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 20,180 | 201,881 | - | - | Stock Option Grant | |
| AMD | Mark D. Papermaster | Chief Technology Officer & EVP | Sale of securities on an exchange or to another person at price $ 128.63 per share. | 10 Feb 2022 | 20,180 | 1,294,632 (0%) | 0% | 128.6 | 2,595,753 | Common Stock |
| Universal Electronics Inc | Bryan M. Hackworth | SVP and CFO | 10 Feb 2022 | 20,175 | 160,565 | - | - | Employee Stock Option (Rt to Buy) | ||
| SiteOne Landscape Supply Inc | Doug Black | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 20,152 | 20,152 | - | - | Stock Options (right to buy) | |
| Airbnb | Belinda J. Johnson | Director | Sale of securities on an exchange or to another person at price $ 165.65 per share. | 10 Feb 2022 | 20,000 | 139,327 | - | 165.7 | 3,313,000 | Class A Common Stock |
| Dynavax Tech Corp | Justin Burgess | Principal Accounting Officer | 10 Feb 2022 | 20,000 | 20,000 | - | - | Restricted Stock Unit | ||
| First Horizon Corp | Terry L. Akins | Sr. EVP, Chief Risk Officer | 10 Feb 2022 | 19,900 | 134,615 (0%) | 0% | 0 | Common Stock | ||
| First Horizon Corp | Hope Dmuchowski | Sr. EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 19,900 | 42,490 (0%) | 0% | 0 | Common Stock | |
| Planet Fitness Inc (Class A) | Shane McGuiness | President, Corporate Clubs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 19,786 | 19,786 (0%) | 0% | 0 | Class A common stock | |
| Bioventus Inc (Class A) | Gregory O. Anglum | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.88 per share. | 10 Feb 2022 | 19,674 | 51,907 (0%) | 0% | 12.9 | 253,401 | Class A Common Stock |
| Herbalife Nutrition Ltd | John G. DeSimone | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 19,565 | 75,378 (0%) | 0% | 0 | Common Stock | |
| Herbalife Nutrition Ltd | John O. Agwunobi | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 19,565 | 108,737 (0%) | 0% | 0 | Common Stock | |
| Devon Energy | Richard E. Muncrief | Director, President and CEO | 10 Feb 2022 | 19,558 | 2,133,356 (0%) | 0% | 52.2 | 1,021,319 | Common Stock | |
| Voya Fin Inc | Rodney O. Martin | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 72.00 per share. | 10 Feb 2022 | 19,365 | 217,364 (0%) | 0% | 72 | 1,394,280 | Common Stock |
| Zentalis Pharma Inc | Cam S. Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 19,245 | 19,245 | - | - | Stock Option (Right to Buy) | |
| Devon Energy | Tana K. Cashion | EVP Human Resources and Admin | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.22 per share. | 10 Feb 2022 | 19,069 | 79,428 (0%) | 0% | 52.2 | 995,783 | Common Stock |
| Onto Innovation Inc | Michael P. Plisinski | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 19,049 | 242,612 (0%) | 0% | 0 | Common Stock | |
| Chipotle Mexican Grill | Brian R. Niccol | Director, Chairman, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 18,738 | 41,377 | - | 0 | common stock | |
| First Horizon Corp | Elizabeth A. Ardoin | SEVP, Chief Communications Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 18,573 | 244,679 (0%) | 0% | 0 | Common Stock | |
| Devon Energy | David A. Hager | Director, Executive Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.22 per share. | 10 Feb 2022 | 18,419 | 979,136 (0%) | 0% | 52.2 | 961,840 | Common Stock |
| Porch Group Inc Ordinary | Matt Ehrlichman | Director, CEO, Chairman and Founder, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.30 per share. | 10 Feb 2022 | 18,263 | 9,183,133 | - | 9.3 | 169,846 | Common Stock |
| PotlatchDeltic Corp | Jerald Richards | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 18,059 | 58,334 (0%) | 0% | 0 | Common Stock | |
| Monarch Casino & Resort Inc | Bob Farahi | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.71 per share. | 10 Feb 2022 | 18,000 | 167,272 (0%) | 0% | 21.7 | 390,780 | Common Stock |
| Monarch Casino & Resort Inc | Bob Farahi | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 18,000 | 248,668 | - | - | Options / Right to Buy | |
| Citigroup | Zdenek Turek | Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 17,970 | 116,519 (0%) | 0% | 0 | Common Stock | |
| Vertex Inc (Class A) | Lisa Butler | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 17,937 | 17,937 | - | - | Restricted Stock Units | |
| Crown Crafts Inc | E. Randall Chestnut | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.02 per share. | 10 Feb 2022 | 17,800 | 231,336 (2%) | 0% | 7.0 | 124,990 | Common Stock |
| Sensient Tech Corp | Paul Manning | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 17,800 | 123,826 (0%) | 0% | 0 | Common Stock | |
| Sensient Tech Corp | Paul Manning | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 17,800 | 0 | - | - | Performance Stock Unit | |
| Taylor Morrison Home Corp | Louis Steffens | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 17,796 | 17,796 | - | - | Restricted Stock Units | |
| NGL Energy Partners LP - Unit | Kurston P. McMurray | Gen Counsel, Exec. VP & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.00 per share. | 10 Feb 2022 | 17,775 | 196,731 (0%) | 0% | 2 | 35,550 | Common Units |
| Sunstone Hotel Investors Inc | Christopher Gerard Ostapovicz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 17,668 | 127,973 (0%) | 0% | - | Common Stock | |
| Sunstone Hotel Investors Inc | Christopher Gerard Ostapovicz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 17,668 | 145,641 (0%) | 0% | - | Common Stock | |
| Louisiana-Pacific Corp | William Bradley Southern | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.89 per share. | 10 Feb 2022 | 17,526 | 456,028 (0%) | 0% | 67.9 | 1,189,840 | Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.20 per share. | 10 Feb 2022 | 17,266 | 567,373 (0%) | 0% | 34.2 | 590,497 | Common Stock |
| Balchem Corp | Theodore L. Harris | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 17,234 | 85,893 (0%) | 0% | 0 | Common Stock | |
| Devon Energy | Jeremy D. Humphers | SVP-Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.22 per share. | 10 Feb 2022 | 17,045 | 75,226 (0%) | 0% | 52.2 | 890,090 | Common Stock |
| Telephone And Data Systems Inc | James W. Butman | Director, President & CEO of subsidiary | 10 Feb 2022 | 16,972 | 55,915 (0%) | 0% | 0 | Common | ||
| Royal Caribbean Cruises | Michael W. Bayley | Pres& CEO,Royal Caribbean Intl | Sale of securities on an exchange or to another person at price $ 88.11 per share. | 10 Feb 2022 | 16,904 | 136,253 (0%) | 0% | 88.1 | 1,489,386 | Common Stock |
| Loews | Kenneth I. Siegel | Senior Vice President | Sale of securities on an exchange or to another person at price $ 61.96 per share. | 10 Feb 2022 | 16,888 | 9,983 (0%) | 0% | 62.0 | 1,046,380 | Common Stock |
| Archer-Daniels-Midland | Gregory A. Morris | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,683 | 291,109 (0%) | 0% | 0 | Common Stock | |
| Archer-Daniels-Midland | Christopher M. Cuddy | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,683 | 294,576 (0%) | 0% | 0 | Common Stock | |
| Archer-Daniels-Midland | Vincent F. Macciocchi | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,683 | 276,448 (0%) | 0% | 0 | Common Stock | |
| Cheesecake Factory Inc | David M. Gordon | PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,650 | 34,500 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.94 per share. | 10 Feb 2022 | 16,598 | 551,844 (0%) | 0% | 34.9 | 579,934 | Common Stock |
| Snap-on | Nicholas T. Pinchuk | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,558 | 16,558 | - | - | Performance Units | |
| Ameren | Michael L. Moehn | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,521 | 153,754 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Zentalis Pharma Inc | Melissa B. Epperly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,405 | 266,407 | - | 0 | Common Stock | |
| Zentalis Pharma Inc | Alexis Pinto | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,405 | 22,931 | - | 0 | Common Stock | |
| Vertex Inc (Class A) | Bryan T. R. Rowland | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,352 | 16,352 | - | - | Restricted Stock Units | |
| Taylor Morrison Home Corp | Darrell C. Sherman | EVP, CLO & Secretary | 10 Feb 2022 | 16,227 | 16,227 | - | - | Employee Stock Option (Right to Buy) | ||
| PJT Partners Inc (Class A) | David A. Travin | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,212 | 18,249 | - | - | LTIP Units of PJT Partners Holdings LP | |
| Stewart Information Services Corp | David C. Hisey | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 16,067 | 65,339 (0%) | 0% | - | Common Stock | |
| Stewart Information Services Corp | David C. Hisey | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 16,067 | 0 | - | - | Restricted Performance Unit | |
| Philip Morris | Emmanuel Babeau | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 102.69 per share. | 10 Feb 2022 | 16,000 | 109,750 (0%) | 0% | 102.7 | 1,643,104 | Common Stock |
| Dynavax Tech Corp | Kelly MacDonald | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 16,000 | 16,000 | - | - | Restricted Stock Unit | |
| Washington Federal Inc | Vincent L. Beatty | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.74 per share. | 10 Feb 2022 | 16,000 | 57,074 (0%) | 0% | 35.7 | 571,840 | Common Stock |
| Dow | Jack Broodo | President, Feedstocks & Energy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 15,620 | 15,620 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Piedmont Office Realty Trust Inc (Class A) | Christopher Brent Smith | Director, President & Chief Exec. Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 15,579 | 221,579 (0%) | 0% | - | Common Stock | |
| Piedmont Office Realty Trust Inc (Class A) | Christopher Brent Smith | Director, President & Chief Exec. Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 15,579 | 96,571 | - | - | Restricted Stock Units | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Sale of securities on an exchange or to another person at price $ 118.35 per share. | 10 Feb 2022 | 15,500 | 30,819 (0%) | 0% | 118.3 | 1,834,388 | Common Stock |
| Sunstone Hotel Investors Inc | David M. Klein | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 15,459 | 217,376 (0%) | 0% | - | Common Stock | |
| Sunstone Hotel Investors Inc | David M. Klein | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 15,459 | 201,917 (0%) | 0% | - | Common Stock | |
| Devon Energy | Dennis C. Cameron | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 15,320 | 322,683 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.64 per share. | 10 Feb 2022 | 15,125 | 580,977 (0%) | 0% | 33.6 | 508,805 | Common Stock |
| Cheesecake Factory Inc | Clark Eliot Matthew | EXEC VP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 15,100 | 28,990 (0%) | 0% | 0 | Common Stock | |
| PNC Financial | E. William Parsley | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.63 per share. | 10 Feb 2022 | 15,048 | 141,245 (0%) | 0% | 210.6 | 3,169,560 | $5 Par Common Stock |
| Box Inc (Class A) | Dylan C. Smith | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 10 Feb 2022 | 15,000 | 1,465,012 (0%) | 0% | 27.0 | 404,955 | Class A Common Stock |
| Pagerduty Inc | Owen Howard Wilson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 15,000 | 231,164 | - | - | Stock Option (Right to Buy) | |
| Pagerduty Inc | Owen Howard Wilson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 10 Feb 2022 | 15,000 | 350,053 (0%) | 0% | 2 | 30,000 | Common Stock |
| Akoustis Technologies Inc | Jeffrey B. Shealy | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 15,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Akoustis Technologies Inc | Jeffrey B. Shealy | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.12 per share. | 10 Feb 2022 | 15,000 | 467,592 (1%) | 0% | 7.1 | 106,800 | Common Stock |
| Akoustis Technologies Inc | Kenneth E. Boller | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 15,000 | 15,000 | - | - | Stock Options (Right to buy) | |
| Raymond James Financial | Bella Loykhter Allaire | Executive Vice President-RJA | Sale of securities on an exchange or to another person at price $ 114.78 per share. | 10 Feb 2022 | 15,000 | 70,357 (0%) | 0% | 114.8 | 1,721,700 | Common Stock |
| Pagerduty Inc | Owen Howard Wilson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 34.04 per share. | 10 Feb 2022 | 14,900 | 333,053 (0%) | 0% | 34.0 | 507,196 | Common Stock |
| Citigroup | Sara Wechter | Head of Human Resources | Sale of securities on an exchange or to another person at price $ 68.56 per share. | 10 Feb 2022 | 14,800 | 57,043 (0%) | 0% | 68.6 | 1,014,614 | Common Stock |
| Cytek BioSciences Inc | Ming Yan | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 10 Feb 2022 | 14,706 | 8,115,086 | - | 15.0 | 220,737 | Common Stock |
| Churchill Downs Inc | William C. Carstanjen | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 14,703 | 354,143 | - | - | Restricted Stock Units | |
| Ameren | Richard J. Mark | Chmn & President of Subsidiary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 14,500 | 163,066 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Yum China Holdings Inc | Alice Wang | Chief Public Affairs Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 14,468 | 14,468 | - | - | Stock Appreciation Right | |
| Collegium pharma Inc | Shirley R. Kuhlmann | EVP and General Counsel | 10 Feb 2022 | 14,341 | 160,297 (0%) | 0% | - | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.